bpc 157 peptide cream BPC-157 BPC-157 10mg Research Peptide UK

Healthcare providers can offer better treatments for diabetic neuropathy with high-dose B12 therapy

A study in Clinical Therapeutics found that the absorption rate of oral B12 can be significantly lower than that of injections, particularly in older adults or those with digestive disorders

In such a study (16-week randomized, double-blind, placebo-controlled), 204 individuals with obesity but not diabetes were treated with self-administered subcutaneous injections of pramlintide (nonforced dose escalation 240 g) or placebo three times a day, 15 minutes before meals without concomitant lifestyle intervention (200)

It shows promise for helping to reduce inflammation in conditions like inflammatory bowel disease (IBD), ulcerative colitis, and arthritis

Benefits: Whos the Best Candidate for Peptide Therapy